- Home
- SPNS vs TARS Comparison
SPNS vs TARS Comparison
Compare SPNS & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPNS
- TARS
- Stock Information
- Founded
- SPNS 1982
- TARS 2016
- Country
- SPNS Israel
- TARS United States
- Employees
- SPNS N/A
- TARS N/A
- Industry
- SPNS Computer Software: Prepackaged Software
- TARS Medicinal Chemicals and Botanical Products
- Sector
- SPNS Technology
- TARS Health Care
- Exchange
- SPNS Nasdaq
- TARS Nasdaq
- Market Cap
- SPNS 1.6B
- TARS 1.8B
- IPO Year
- SPNS 1992
- TARS 2020
- Fundamental
- Price
- SPNS $28.39
- TARS $40.65
- Analyst Decision
- SPNS Buy
- TARS Strong Buy
- Analyst Count
- SPNS 4
- TARS 7
- Target Price
- SPNS $34.25
- TARS $67.14
- AVG Volume (30 Days)
- SPNS 133.2K
- TARS 552.3K
- Earning Date
- SPNS 07-31-2025
- TARS 08-07-2025
- Dividend Yield
- SPNS 3.35%
- TARS N/A
- EPS Growth
- SPNS 11.11
- TARS N/A
- EPS
- SPNS 1.30
- TARS N/A
- Revenue
- SPNS $544,235,000.00
- TARS $233,674,000.00
- Revenue This Year
- SPNS $8.30
- TARS $122.94
- Revenue Next Year
- SPNS $7.42
- TARS $44.14
- P/E Ratio
- SPNS $21.86
- TARS N/A
- Revenue Growth
- SPNS 3.84
- TARS 449.03
- 52 Week Low
- SPNS $23.69
- TARS $20.08
- 52 Week High
- SPNS $41.22
- TARS $57.28
- Technical
- Relative Strength Index (RSI)
- SPNS 48.36
- TARS 40.26
- Support Level
- SPNS $27.82
- TARS $39.25
- Resistance Level
- SPNS $28.80
- TARS $42.01
- Average True Range (ATR)
- SPNS 0.52
- TARS 1.93
- MACD
- SPNS -0.14
- TARS -0.05
- Stochastic Oscillator
- SPNS 21.92
- TARS 22.95
About SPNS Sapiens International Corporation N.V. (Cayman Islands)
Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.